ABSTRACT. We evaluated the effectiveness of adminis-GPI-lB, B isoenzyme of GPI-1 tration of high-dose busulfan (BU), an alkylating agent HCT, hematopoietic cell transplantation with substantial myeloablative but negligible immunosup-TBI, total body irradiation pressive properties, on the engraftment of congenic normal bone marrow and spleen cells (hematopoietic cell transplantation; HCT) in murine galactosylceramidase deficiency (the twitcher mouse), a model of human sphingolipid storage disease. Untreated mice died with extensive de-
In this report, we describe the effectiveness of high-dose BU as from the March of Dimes Birth a myeloablative preparative agent for congenic HCT in the Defects Foundation, White Plains, NY, and by grants from The Children's Cancer twitcher model of galactosylceramidase deficiency. We compared Foundation, Inc., Baltimore, MD, The National Children's Cancer Society, Inc., the effects of HCT after BU administration on the survival, Mice. Breeding pairs of congenic C57BL/6 mice that were heterozygous for the twitcher mutation (+/twi) or homozygous for GPI-1A were obtained from the Jackson Laboratory, Bar Harbor, ME. Normally, the C57BL/6 strain, including the twitcher mutation, is homozygous for the codominant GPI-1 B (22). Hematopoietic cell transplants were carried out from congenic GPI-1A donors (which have normal tissue activity of galactosylceramidase) into recipient GPI-IB twitcher offspring or normal littermates; engraftment was assessed by electrophoretic analysis of 5-to 10-pL blood samples from recipient mice to detect donor GPI-1 A isoenzyme (23). All animals were housed in sterilized shoebox-type plastic cages and given sterilized standard laboratory food and tap water ad libitum. Litters were housed with sire and dam until time of weaning. Galactosylceramidase activity in samples of homogenized clipped tail tips of 7-d-old offspring (24) identified their genetic status (twitcher, heterozygous camer, or normal). Behavioral observations provided clinical identification of affected (twi/twi) offspring, in which the onset of neurologic symptoms occurs at approximately 21 d of age (15) (16) (17) . This study was reviewed and approved by the Animal Care and Use Committee of The Johns Hopkins Medical Institutions, and mice were maintained according to National Institutes of Health Guidelines for Humane Care of Laboratory Animals.
HCT procedure. BU (Aldrich Chemical Co., Milwaukee, WI) was solubilized in acetone and suspended in 1 % carboxymethylcellulose (Sigma Chemical Co., St. Louis, MO) at a final BU concentration of 3.0 mg/mL. Cohorts of twitcher mice and control littermates received single intraperitoneal injections of BU (100 mg/kg/mouse) at age 9 d, followed by HCT 24 h later. Congenic normal 6-to &wk-old GPI-IA mice were killed by lethal carbon dioxide narcosis, and single-cell suspensions of donor bone marrow were prepared by flushing the cavities of humeri and femora into Hanks' balanced salt solution (GIBCO, Grand Island, NY) and repetitive gentle pipetting of marrow plugs to disperse the clumps of cells. Donor spleens were gently teased with forceps through a fine stainless steel wire mesh (Newark Wire Cloth Co., Newark, NJ) into Hanks' balanced salt solution, and a single-cell suspension was obtained by repetitive pipetting with a sterile Pasteur pipette. To insure sufficient congenic donor cells for engraftment, each recipient mouse was given 10-1 5 x lo6 bone marrow cells and 35-50 x lo6 spleen cells by intraperitoneal injection with a tuberculin syringe and a 26-or 30-gauge needle. For 10 to 14 d after HCT, mice were provided with acidified drinking water (pH 2.0-2.5) to which was added prophylactic neomycin (final concentration 500 pg/ mL), polymyxin B (final concentration 13 pg/mL), and trimethoprim-sulfamethoxazole (final concentration as trimethoprim 100 pg/mL). At selected times after HCT, blood samples were obtained from the retroorbital plexus of recipient animals, and electrophoretic determination of GPI-1 isoenzymes was carried out (23) to assess engraftment.
Biochemical assays. At selected times after HCT, animals were deeply anesthetized with methoxyflurane. After blood samples were obtained by direct cardiac puncture, the animals were perfused with normal saline to remove contaminating blood from organs and tissues. Samples of spleens and lymph nodes were prepared for GPI-1 determination by homogenization in distilled water with a Dounce micro-homogenizer type tissue grinder (Wheaton Glass Co., Vineland, NJ). Samples of blood, bone marrow, lymph nodes, and spleens of transplanted twitcher mice were analyzed for GPI-1 isozymes by electrophoresis on cellulose acetate plates (Titan 111; Helena Laboratories, Helena, MT) in a microelectrophoresis chamber (Helena) and staining with phenazine-thiazol blue in an agar overlay, according to published methods (9, 23) . This technique demonstrates a discrete band ofactivity for each GPI-1 isoenzyme (A or B). Samples of tail tips, approximately 1 cm long, were obtained from 7-dold mice and homogenized on 1 mL of distilled water using a microhomogenizer. Aqueous homogenates of these tail tips and of samples of kidney, cervical lymph node, liver, spleen, brain, and sciatic nerve from untreated and saline-perfused HCTtreated twitcher mice and from control normal littermates were tested for total protein content with the spectrophotometric method of Lowry et al. (25) , and activity of galactosylceramidase (EC 3.2.1.46) in these samples was assayed at pH 3.8 using tritiated galactosylceramide as the substrate (24, 26, 27) . Enzyme activity was expressed as a function of protein content in each sample.
Neuropathologic studies. At selected times after HCT, twitcher mice were deeply anesthetized with methoxyflurane and perfused through the ascending aorta with a rinse of normal saline solution and then with 5% glutaraldehyde (28). The sciatic nerves and nerve roots were then dissected, and 3.0-mm segments of the nerves were dehydrated in graded alcohols, embedded in Epon, and cut in 1 pm-thick transverse sections. The sections were stained with toluidine blue and examined with light microscopy to determine qualitatively the integrity of myelin sheaths and the degree of remyelination in the posttransplant period.
Statistical analysis. Routine statistical calculations were performed with a hand-held calculator (Texas Instruments, Inc., Lubbock, TX). Statistical evaluation of the data was carried out with the two-sample t and Wilcoxon rank-sum tests, using a personal microcomputer (IBM Corp., Armonk, NY) and software packages developed by the Biostatistics and Information Systems Division of The Johns Hopkins Oncology Center.
RESULTS

ESfecls of HCT on survival and neuropathology of twitcher mice.
Untreated twitcher mice appeared normal for the first 3 wk of life, then developed truncal tremor, hindlimb paralysis, and impairment ofgait, foraging, and grooming behaviors. These animals died with progressive neurodegeneration and failure to thrive at a median of 40 d of age (range, 28-47) ( Table I ). The survival of twitcher mice given high-dose BU followed by HCT from congenic normal GPI-1 A donors at age 10 d was significantly prolonged relative to that of untreated mice: the median survival of transplanted twitcher mice was 94 d (range, 55-140) ( Table 1) . Twitcher recipients of HCT had improved gait and did not develop the characteristic hindlimb paralysis seen in untreated twitchers. Histopathologic examination of sciatic nerves from untreated preterminal twitcher mice showed preservation of axons, infiltration with mononuclear cells (some of which contained characteristic globoid cell inclusions), perineurial edema, and total loss of myelin sheaths, as previously reported (29). In contrast, sciatic nerves from 100-d-old BU-treated animals (90 d after HCT) showed areas of remyelinated axons, decreased edema and mononuclear cells, and only rare inclusions (Fig. 1) .
Engrafiment and lymphohematopoietic repopulation afier HCT. Donor-derived GPI-1A activity was first detected in the blood of twitcher mice 14-21 d after HCT following high-dose BU, along with residual recipient GPI-1B isoenzyme. Six to seven wk after transplant, only donor GPI-1A activity was present in the blood. Despite its lack of immediate lympholytic or Qf)g 9 '1 after HCT following high-dose BU, donor-derived enzyme was from only 4 to 20% of values in control littermates; by 3 mo ? +, (2 ' detected in most tissues. Galactosylceramidase levels in kidneys
of transplanted twitcher mice were not significantly different from values in untreated affected animals and increased only modestly in lymph nodes. In contrast, galactosylceramidase in livers and spleens of BU-conditioned twitcher HCT recipients rose to 45 and 80% of control, respectively, representing 7-to 9- Fig. I . Photomicrograph of sciatic nerve from 100-d-old twitcher fold elevations of enzyme activity in untreated twitchers. Highmouse, 90 d after administration of high-dose BU and HCT from dose BU and HCT also provided enzyme replacement in both enzymatically normal congenic donors. Areas of remyelination and intact the central and peripheral nervous systems of twitcher mice, even myelin sheaths are present, as indicated by the darkly staining regions though no specific techniques were used to disrupt the bloodsurrounding the axons. Toluidine blue stain; x693 magnification.
brain or blood-nerve barrier. Three mo after transplant, galactosylceramidase activity in twitcher brains increased significantly immunosuppressive effects, BU administration in preparation for HCT was effective for repopulation of recipient lymphoid tissue with donor cells as well. Lymph nodes obtained from transplanted 100-d-old twitcher mice (90 d after HCT) demonstrated donor GPI-1 A activity (Fig. 2) . Bone marrow and spleen, which contain both lymphoid and hematopoietic cells in the mouse, also had significant donor GPI activity after BU and HCT (Fig. 2) . Residual recipient GPI-1B isoenzyme in these samples was most likely due to the presence of nonlymphoheIn this demyelinating murine sphingolipidosis, pre-HCT myeloablative conditioning with high-dose BU leads to sustained engraftment of both lymphoid and hematopoietic congenic donor cells, even though BU is not immunosuppressive. The similar prolongation of survival, histopathologic improvement, and biochemical correction in twitcher mice given HCT after treatment with either high-dose BU or TBI strongly suggest that the favorable effects of HCT in this lysosomal storage disease model are attributable primarily to engraftment of enzymatically normal cells and not necessarily to effects of the pretransplant regimen on immune function or integrity of organs or tissues.
Although HCT after high-dose BU provides donor-derived galactosylceramidase in most tissues of twitcher mice, enzyme levels in the kidney remained low, as seen after HCT with TBI conditioning (10, 14) . This observation is consistent with the absence in the kidney of significant lymphoid, hematopoietic, or reticuloendothelial cells, which are repopulated with donor cells after HCT. Furthermore, although this study did not examine 4 p < 0.05 compared with enzyme activity in untreated twitcher mice.
4 p < 0.001 compared with enzyme activity in untreated twitcher mice.
11 p < 0.01 compared with enzyme activity in untreated twitcher mice.
